American Journal of Physiology-Endocrinology and Metabolism, published by the American Physiological Society, stands as a leading platform for disseminating high-quality research in the fields of endocrinology, diabetes, and metabolism, as well as general physiology. With an impressive impact factor placing it within the Q1 category across multiple relevant disciplines (Endocrinology, Diabetes and Metabolism; Physiology; and Medical Physiology), this journal reflects its authoritative position in the scientific community. Spanning from 1980 to 2024, the journal consistently publishes groundbreaking studies and significant findings that advance our understanding of hormonal regulation and metabolic processes. Although it does not currently offer open access, it provides valuable resources for researchers, professionals, and students alike, eager to stay at the forefront of advancements in physiological sciences. Addressed in Rockville, Maryland, its commitment to excellence and rigorous peer review ensures that every article contributes essential insights to the field.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, published by Elsevier, is a leading academic journal that focuses on advancing the field of lipid biology. With an ISSN of 1388-1981 and an E-ISSN of 1879-2618, this journal has established itself as an essential resource for researchers, professionals, and students interested in cell and molecular biology, particularly regarding lipid interactions and functions. The journal boasts an impressive impact factor, standing in the top quartiles of its categories—Q1 in Molecular Biology and Q2 in Cell Biology. As part of the vibrant academic landscape of the Netherlands, it supports both traditional and open access publication models, ensuring that vital research is accessible to a global audience. The converged years from 1998 to 2025 mark its sustained commitment to quality and relevance in the fast-evolving field of lipid research. With a strong ranking in Scopus and a percentile in the 80th range in both Molecular Biology and Cell Biology, this journal continues to be a pivotal platform for scholarly communication and innovation in lipid-related research.

Welcome to BIOCHIMIE, a prestigious journal dedicated to advancing the field of biochemistry and related areas of medicine. Published by Elsevier France - Editions Scientifiques Medicales Elsevier, this journal has been a cornerstone of scientific communication since its inception in 1971 and will continue to contribute essential research until 2024. With an impressive impact factor and categorized in Q2 for Biochemistry and Q1 for Miscellaneous Medicine, BIOCHIMIE ranks among the top quartiles in its fields, underscoring its significance and influence in the scientific community. Targeting a wide audience of researchers, professionals, and students, the journal publishes high-quality articles that explore innovative research and developments in biochemistry, genetics, and molecular biology, reflected in its Scopus ranking of 136 out of 438 in the biochemistry category. Despite its traditional publication format, the journal remains committed to promoting impactful research that drives the future of biochemistry and molecular medicine, ensuring that readers have access to critical insights that foster advancements in health and science.

Lipids in Health and Disease, published by BMC, stands as a leading open-access journal dedicated to advancing the understanding of lipid metabolism and its implications for health and disease. Since its inception in 2002, this journal has fostered accessibility to cutting-edge research, ensuring that knowledge in this vital field is disseminated widely to researchers, clinicians, and students worldwide. With a commendable Q1 ranking in multiple categories including Clinical Biochemistry and Endocrinology, Diabetes and Metabolism, it appeals to a diverse readership, positioning itself at the forefront of research in biochemistry and medicine. It boasts an impressive Scopus rank, where it excels in areas such as Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, making it an essential resource for those looking to deepen their understanding of lipid biology and its clinical applications. Researchers can share and access findings that have significant implications for public health and disease prevention, emphasizing the journal's commitment to fostering innovation and collaboration in the scientific community.

BIOLOGICHESKIE MEMBRANY is a critical journal in the field of Cell Biology and Molecular Biology, published by MEZHDUNARODNAYA KNIGA in the Russian Federation. With an ISSN of 0233-4755, this journal has been serving the academic community since 1996 and continues to publish cutting-edge research that advances our understanding of biological membranes and their functions. Despite being classified in Q4 quartiles for both Cell and Molecular Biology in the 2023 category rankings, the journal presents a unique platform for emerging research within these pivotal areas. Researchers, professionals, and students alike will find valuable insights in its pages as it seeks to foster a collaborative environment that encourages knowledge sharing. Although currently not available as an open-access journal, it remains an essential resource for those looking to deepen their knowledge and contribute to ongoing discussions in the biological sciences. The journal’s commitment to publishing quality research is underscored by its continuous coverage until 2024, making it a sustained reference in the field.

Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.

AIMS Biophysics, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed open-access journal dedicated to advancing the fields of biophysics, biochemistry, molecular biology, and structural biology. Launched in 2014, this journal provides a platform for researchers and professionals to disseminate high-quality research findings that contribute to the understanding of complex biological systems at the molecular level. With an ISSN of 2377-9098, AIMS Biophysics is indexed in Scopus, where it ranks in the fourth quartile across several categories, reflecting its commitment to addressing important issues within the scientific community. The journal aims to foster interdisciplinary collaboration and innovation through the publication of original research, reviews, and methodologies that advance the field. The open-access model ensures that cutting-edge research is freely available, promoting global access to scientific knowledge and enhancing visibility for authors. Nestled in the vibrant scientific landscape of the United States, AIMS Biophysics is poised to impact the evolving discourse in biophysics and related areas as it continues through its convergence period from 2014 to 2024.

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to the study of bioenergetics and biomembranes, covering essential topics such as cellular energy transformation and membrane dynamics. Since its inception in 1976, the journal has developed a robust reputation within the scientific community, currently holding a Q3 ranking in Cell Biology and a Q2 ranking in Physiology for 2023. Boasting a prestigious Scopus Rank in both Biochemistry and Physiology, it serves as a crucial platform for disseminating pioneering research findings. With its commitment to quality and innovation, the journal plays a significant role in advancing our understanding of the fundamental processes that underlie life at the cellular level. Although it does not offer open access options, the journal remains accessible through universities and research institutions, ensuring that vital research is widely shared among scholars, professionals, and students alike. The JOURNAL OF BIOENERGETICS AND BIOMEMBRANES is essential for anyone seeking to contribute to or stay informed about developments in this dynamic field.

BIOPHYSICAL CHEMISTRY, published by Elsevier, is a prestigious journal with a long-standing tradition since its inception in 1973. This highly respected journal focuses on the intersections of biochemistry, biophysics, and organic chemistry, providing a critical platform for researchers, professionals, and students to disseminate pivotal findings in these dynamic fields. With an impressive impact factor that reflects its robust academic influence and high citation rates, it ranks within the Q2 quartile among its peers in multiple categories, indicating its significance in the scholarly community. The journal, hosted in the Netherlands, encompasses a diverse range of topics, from molecular interactions to protein folding, and serves as an essential resource for those engaged in cutting-edge research. Researchers looking to share their work with a global audience will find BIOPHYSICAL CHEMISTRY an invaluable outlet, fostering the advancement of knowledge in this crucial area of science. For more information, visit the journal's page on the Elsevier platform.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.